Sally Pipes

2 weeks ago | newsmax.com | Sally Pipes

Don't Target HSAs - They Can Work for EveryoneIt's been two decades since Congress created health savings accounts, vehicles that enable people to set aside money tax-free for future health expenses. They've injected a dose of consumerism into the medical marketplace β€” and empowered millions of people to take greater control of their care. But many millions more still lack access to them. That may soon change.

2 weeks ago | pacificresearch.org | Sally Pipes

The legislative package would codify and expand Individual Coverage Health Reimbursement Arrangements, which the first Trump administration introduced in 2019. ICHRAs allow employers to give workers untaxed dollars, which they can use to purchase health insurance on the individual market. In many ways, ICHRAs are the health insurance equivalent of retirement accounts to which employers make defined contributions.

2 weeks ago | forbes.com | Sally Pipes

"The legislative package would codify and expand Individual Coverage Health Reimbursement ... More Arrangements, which the first Trump administration introduced in 2019," writes health policy expert Sally Pipes. Getty ImagesThere are more than 40 healthcare provisions in the One Big Beautiful Bill Act (OBBBA) that passed the House of Representatives by a one-vote margin last month. One, in particular, deserves more attention than it is getting.

3 weeks ago | pacificresearch.org | Sally Pipes

President Trump announced his intention last month to peg U.S. drug prices to those that foreign governments have set within their borders. The very same day, federal officials said they’d reveal in February 2026 a list of 15 drugs subject to price controls through Medicare’s Part B outpatient benefit and Part D prescription drug benefit starting in 2028. The widespread embrace of price controls in Washington is bad news for patients.

3 weeks ago | newsmax.com | Sally Pipes

Congress Must Act Now to Preserve Drug InnovationPresident Trump announced his intention last month to peg U.S. drug prices to those that foreign governments have set within their borders. The very same day, federal officials said they'd reveal in February 2026 a list of 15 drugs subject to price controls through Medicare's Part B outpatient benefit and Part D prescription drug benefit starting in 2028. The widespread embrace of price controls in Washington is bad news for patients.